Bio-Techne Corp (TECH) — 10-Q Filings

10-Q Filings (6)

• BIO-TECHNE's Net Income Rises Despite Sales Dip — Nov 5, 2025 Risk: medium
  BIO-TECHNE Corp reported a mixed financial performance for the quarter ended September 30, 2025. Net sales decreased slightly to $286.555 million from $289.458
• Bio-Techne Corp. Files Q3 2025 10-Q — May 8, 2025 Risk: low
  Bio-Techne Corp. filed its 10-Q for the period ending March 31, 2025. The company, headquartered in Minneapolis, MN, operates in the biological products sector.
• Bio-Techne Corp Files Q2 2025 10-Q — Feb 6, 2025 Risk: low
  Bio-Techne Corp filed its 10-Q for the period ending December 31, 2024. The company, incorporated in Minnesota, operates in the biological products sector. Its
• Bio-Techne Corp. Files Q1 2025 10-Q — Nov 5, 2024 Risk: low
  Bio-Techne Corp. reported its first quarter results for the fiscal year ending June 30, 2025. The company's filing on November 5, 2024, covers the period ending
• BIO-TECHNE Corp Files 10-Q for Period Ending March 31, 2024 — May 6, 2024 Risk:
  BIO-TECHNE Corp (TECH) filed a Quarterly Report (10-Q) with the SEC on May 6, 2024. BIO-TECHNE Corp filed its 10-Q report for the period ending March 31, 2024.
• BIO-TECHNE Corp Files 10-Q for Period Ending December 31, 2023 — Feb 7, 2024 Risk: low
  BIO-TECHNE Corp (TECH) filed a Quarterly Report (10-Q) with the SEC on February 7, 2024. BIO-TECHNE Corp filed a 10-Q report for the period ending December 31,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX